Free Trial
→ Trump’s New Order Could Boost Social Security Benefits by 400% (From InvestorPlace) (Ad) Free ADVM Stock Alerts

Adverum Biotechnologies (ADVM) SEC Filings & 10K Form

Adverum Biotechnologies logo
$2.26 -0.02 (-0.88%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$2.29 +0.03 (+1.50%)
As of 07/2/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Adverum Biotechnologies SEC Filings

Export to Excel
DateFilerForm TypeView
06/20/2025
3:21 PM		Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
3:22 PM		Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
3:23 PM		Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
3:23 PM		Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
3:24 PM		Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
7:00 AM		Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
7:27 AM		Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13D
05/16/2025
3:44 PM		Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
3:45 PM		Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
3:46 PM		Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
8:15 AM		Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13G/A
04/28/2025
2:24 PM		Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
2:31 PM		Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4/A
04/24/2025
8:35 AM		Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2025
6:30 AM		Adverum Biotechnologies (Filer)
Form PRE 14A
04/15/2025
6:30 AM		Adverum Biotechnologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2025
6:43 AM		Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
5:07 PM		Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
6:06 PM		Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
7:02 PM		Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:04 PM		Adverum Biotechnologies (Issuer)
Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:59 PM		Adverum Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2025
5:10 PM		Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
2:25 PM		Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SCHEDULE 13G/A
12/19/2024
3:14 PM		Adverum Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/17/2024
4:11 PM		Adverum Biotechnologies (Subject)
Rush Ryan Bradford (Filed by)
Form SCHEDULE 13G
11/14/2024
5:40 PM		Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
11/14/2024
5:57 PM		Adverum Biotechnologies (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G/A
11/06/2024
4:49 PM		Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
11/04/2024
3:42 PM		Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:44 PM		Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
11:41 AM		Adverum Biotechnologies (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G
10/30/2024
8:34 PM		Adverum Biotechnologies (Subject)
Stern Augustus (Filed by)
Form SC 13G
10/23/2024
12:34 PM		Adverum Biotechnologies (Subject)
Principia Wealth Advisory, LLC (Filed by)
Form SC 13G
10/22/2024
5:06 PM		Adverum Biotechnologies (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/12/2024
3:08 PM		Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:10 PM		Adverum Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2024
3:24 PM		Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G/A
07/18/2024
8:16 PM		Adverum Biotechnologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:16 PM		Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
8:16 PM		Adverum Biotechnologies (Issuer)
Leonard Braden Michael (Reporting)
Leonard Braden Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
Banks aren’t ready for this altcoin—are you? (Ad)

Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…

Discover our #1 crypto for the market right now.
07/17/2024
3:38 PM		Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ADVM) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners
Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
Timothy Sykes | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...
Crypto 101 Media | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored